With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells||University of California Berkeley / Erin Simonds, PhD||Young Investigator Grants||2013||California|
|Role of Fetal Growth in Pediatric Rhabdomyosarcoma||University of California Berkeley / Catherine Metayer, MD, PhD||Epidemiology Grants||2013||California|
|Evaluation of the Literacy Demand and Racial/Ethnic Influences for Self-Reported Symptomatic Adverse Events during Childhood Cancer Therapy||Palmetto Health / Janice Withycombe, PhD||Nurse Researcher Grants||2013||South Carolina|
|Moving EphB4 Therapeutics to Pediatric Phase I/II Trials||Oregon Health & Science University / Charles Keller, MD||Reach Grants||2013||Oregon|
|Molecular Signature of Inflammation||Medical College of Wisconsin / Subramaniam Malarkannan, PhD||Springboard Grants||2013||Wisconsin|
|The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis||Mayo Clinic / Shizhen Zhu, MD, PhD||Young Investigator Grants||2013||Minnesota|
|IDO-based Immunotherapy for Pediatric Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, MD, PhD||'A' Award Grants||2013||Georgia|
|Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma||Duke University Medical Center / David Van Mater, MD, PhD||Young Investigator Grants||2013||North Carolina|
|Nitrosative Stress And Symptom Severity During Childhood Leukemia Treatment||Duke University Medical Center / Marilyn Hockenberry, RN, PhD||Nurse Researcher Grants||2013||North Carolina|
|Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma||Duke University Medical Center / Gerard Blobe, MD, PhD||Reach Grants||2013||North Carolina|